eli lilly retatrutide study Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments retatrutide weight loss clinical trial

Mistake #3: Ignoring Muscle Lean-mass preservation with protein & strength training How this shows up: Youre eating less (which is the goal), but youre also eating far less protein and skipping strength work

The behaviors you establish while on the medication form the foundation for whatever comes next

Legislative, Regulatory, or Systems Change Will Be Needed : CMS staff have been working within existing authorities to remove Medicare-Medicaid misalignments

Ensure protein intake stays at target despite reduced hunger

Lets break down how they work, what makes them different, and how to decide which option may be right for you